Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Jane Wimpfheimer Newburger, M.D.

Co-Author

This page shows the publications co-authored by Jane Newburger and Robert Sundel.
Connection Strength

2.645
  1. Corticosteroids in the initial treatment of Kawasaki disease: report of a randomized trial. J Pediatr. 2003 Jun; 142(6):611-6.
    View in: PubMed
    Score: 0.280
  2. Primary adjunctive corticosteroid therapy is associated with improved outcomes for patients with Kawasaki disease with coronary artery aneurysms at diagnosis. Arch Dis Child. 2021 03; 106(3):247-252.
    View in: PubMed
    Score: 0.232
  3. Risk Model Development and Validation for Prediction of Coronary Artery Aneurysms in Kawasaki Disease in a North American Population. J Am Heart Assoc. 2019 06 04; 8(11):e011319.
    View in: PubMed
    Score: 0.212
  4. Predicting Coronary Artery Aneurysms in Kawasaki Disease at a North American Center: An Assessment of Baseline z Scores. J Am Heart Assoc. 2017 May 31; 6(6).
    View in: PubMed
    Score: 0.185
  5. Idiopathic pericarditis and pericardial effusion in children: contemporary epidemiology and management. J Am Heart Assoc. 2014 Nov 07; 3(6):e001483.
    View in: PubMed
    Score: 0.155
  6. Kawasaki disease and its cardiac sequelae. Hosp Pract (Off Ed). 1993 Nov 15; 28(11):51-4, 57-60, 64-6.
    View in: PubMed
    Score: 0.145
  7. Gamma globulin re-treatment in Kawasaki disease. J Pediatr. 1993 Oct; 123(4):657-9.
    View in: PubMed
    Score: 0.143
  8. Infliximab for intravenous immunoglobulin resistance in Kawasaki disease: a retrospective study. J Pediatr. 2011 Apr; 158(4):644-649.e1.
    View in: PubMed
    Score: 0.118
  9. Performance of 2004 American Heart Association recommendations for treatment of Kawasaki disease. Pediatrics. 2010 Feb; 125(2):e234-41.
    View in: PubMed
    Score: 0.111
  10. Treatment of Kawasaki disease: analysis of 27 US pediatric hospitals from 2001 to 2006. Pediatrics. 2009 Jul; 124(1):1-8.
    View in: PubMed
    Score: 0.107
  11. Characteristics of children discharged from hospitals in the United States in 2000 with the diagnosis of acute rheumatic fever. Pediatrics. 2007 Sep; 120(3):503-8.
    View in: PubMed
    Score: 0.094
  12. Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease. N Engl J Med. 2007 Feb 15; 356(7):663-75.
    View in: PubMed
    Score: 0.091
  13. Coronary artery dilation among patients presenting with systemic-onset juvenile idiopathic arthritis. Pediatrics. 2005 Jul; 116(1):e89-93.
    View in: PubMed
    Score: 0.080
  14. Aortic root dilation in Kawasaki disease. Am J Cardiol. 2001 Apr 01; 87(7):919-22.
    View in: PubMed
    Score: 0.060
  15. Cyclophosphamide use in treatment of refractory Kawasaki disease with coronary artery aneurysms. Pediatr Rheumatol Online J. 2021 Mar 17; 19(1):31.
    View in: PubMed
    Score: 0.060
  16. Multiple Emergency Department Visits for a Diagnosis of Kawasaki Disease: An Examination of Risk Factors and Outcomes. J Pediatr. 2021 05; 232:127-132.e3.
    View in: PubMed
    Score: 0.059
  17. Distinct clinical and immunological features of SARS-CoV-2-induced multisystem inflammatory syndrome in children. J Clin Invest. 2020 11 02; 130(11):5942-5950.
    View in: PubMed
    Score: 0.059
  18. Ticlopidine plus aspirin for coronary thrombosis in Kawasaki disease. Pediatrics. 2000 May; 105(5):E64.
    View in: PubMed
    Score: 0.057
  19. Adenosine deaminase 2 as a biomarker of macrophage activation syndrome in systemic juvenile idiopathic arthritis. Ann Rheum Dis. 2020 02; 79(2):225-231.
    View in: PubMed
    Score: 0.055
  20. Coronary artery dimensions may be misclassified as normal in Kawasaki disease. J Pediatr. 1998 Aug; 133(2):254-8.
    View in: PubMed
    Score: 0.050
  21. A predictive instrument for coronary artery aneurysms in Kawasaki disease. US Multicenter Kawasaki Disease Study Group. Am J Cardiol. 1998 May 01; 81(9):1116-20.
    View in: PubMed
    Score: 0.049
  22. Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids. J Pediatr. 1996 Jan; 128(1):146-9.
    View in: PubMed
    Score: 0.042
  23. Urine proteomics for discovery of improved diagnostic markers of Kawasaki disease. EMBO Mol Med. 2013 Feb; 5(2):210-20.
    View in: PubMed
    Score: 0.034
  24. Audiologic profiles of children with Kawasaki disease. Am J Otol. 1992 Nov; 13(6):512-5.
    View in: PubMed
    Score: 0.034
  25. Sensorineural hearing loss associated with Kawasaki disease. J Pediatr. 1990 Sep; 117(3):371-7.
    View in: PubMed
    Score: 0.029
  26. Delayed diagnosis of Kawasaki disease: what are the risk factors? Pediatrics. 2007 Dec; 120(6):e1434-40.
    View in: PubMed
    Score: 0.024
  27. Gene-expression patterns reveal underlying biological processes in Kawasaki disease. Genome Biol. 2007; 8(12):R261.
    View in: PubMed
    Score: 0.022
  28. Family-based association analysis implicates IL-4 in susceptibility to Kawasaki disease. Genes Immun. 2005 Aug; 6(5):438-44.
    View in: PubMed
    Score: 0.020
  29. Physical and psychosocial health in children who have had Kawasaki disease. Pediatrics. 2003 Mar; 111(3):579-83.
    View in: PubMed
    Score: 0.017
  30. Psoriatic eruption in Kawasaki disease. J Pediatr. 2000 Oct; 137(4):578-80.
    View in: PubMed
    Score: 0.015
  31. Decreased protein binding of salicylates in Kawasaki disease. J Pediatr. 1991 Mar; 118(3):456-9.
    View in: PubMed
    Score: 0.007
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.